HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

histidylhistidine (His-His)

RN given for L-,L-isomer
Also Known As:
His-His; histidylhistidine, (DL)-(DL)-isomer
Networked: 67 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wang, Na: 3 articles (03/2012 - 12/2003)
2. Guo, Yongli: 2 articles (04/2012 - 09/2010)
3. Yu, Dianke: 2 articles (04/2012 - 09/2010)
4. Zhang, Xuemei: 2 articles (04/2012 - 09/2010)
5. Boffetta, Paolo: 2 articles (01/2012 - 05/2002)
6. Brennan, Paul: 2 articles (01/2012 - 05/2002)
7. Arzani, Dario: 2 articles (11/2007 - 11/2005)
8. Boccia, Stefania: 2 articles (11/2007 - 11/2005)
9. D'Ugo, Domenico: 2 articles (11/2007 - 11/2005)
10. Gianfagna, Francesco: 2 articles (11/2007 - 11/2005)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
12/01/2012 - "HSP90 GG (His/His) genotype was associated with elevated breast cancer risk. "
11/01/2005 - "The SULT1A1 genotype was found to significantly modify postmenopausal breast cancer risk associated with a high BMI (>or=25 kg/m2) (p for interaction = 0.02), with an adjusted OR of 3.6 (95% CI = 1.5-8.7) for women with the Arg/His genotype compared with 1.1 (0.8-1.5) for women with the Arg/Arg genotype (no His/His genotype was identified in this study population). "
11/01/2014 - "The results demonstrated that the XPG Asp1104His polymorphism was not associated with breast cancer in the overall population [His vs. Asp, odds ratio (OR)=1.00, 95% confidence interval (CI): 0.91-1.08; His/His vs. Asp/Asp, OR=0.96, 95% CI: 0.83-1.11; Asp/His vs. Asp/Asp, OR=1.02, 95% CI: 0.94-1.11; His/His+Asp/His vs. Asp/Asp, OR=1.03, 95% CI: 0.92-1.15; and His/His vs. Asp/Asp+Asp/His, OR=0.93, 95% CI: 0.81-1.06]. "
02/01/2001 - "The risk of breast cancer was elevated with increasing doneness level of red meat intake among women with the Arg/Arg genotype (P for trend, 0.01) or the Arg/His genotype (P for trend, 0.10), whereas this association was not evident for women with the His/His genotype. "
01/01/2011 - "When all the 21 studies were pooled into the meta-analysis, there was no evidence for significant association between SULT1A1 codon 213 polymorphism and breast cancer susceptibility (for Arg/Arg versus Arg/His: OR = 0.999, 95% CI = 0.941-1.061; for Arg/Arg versus His/His: OR = 1.121, 95% CI = 1.013-1.242; for dominant model: OR = 1.128, 95% CI = 1.01-1.26; for recessive model: OR = 1.151, 95% CI = 0.950-1.394). "
2. Neoplasms (Cancer)
3. Alzheimer Disease (Alzheimer's Disease)
4. Genetic Predisposition to Disease (Genetic Predisposition)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. arginylarginine (Arg-Arg)
2. aspartyl-aspartic acid (Asp-Asp)
3. Codon (Codons)
4. Amyloid beta-Peptides
5. Peptides (Polypeptides)
6. Copper
7. arginyl-glutamine
8. Proteins (Proteins, Gene)
9. glutamyl-glutamic acid (Glu-Glu)
10. tyrosyltyrosine (Tyr-Tyr)

Related Therapies and Procedures

1. Therapeutics